Understanding concentrated insulins: a systematic review of randomized controlled trials.

CONCLUSION: Concentrated-insulin products demonstrated efficacious and safe outcomes in appropriate patients. Clinical findings (HbA1c and hypoglycemia) and methodology (initiation and titration), patient factors (insulin experience and dosing requirements), and treatment characteristics (bioequivalence, potency, and device features) are important considerations. This overview of these and other factors provides essential information and guidance for using concentrated insulins in clinical practice.
PMID: 29166786 [PubMed - as supplied by publisher]

Source: Current Medical Research and Opinion - November 25, 2017 Category: Research Tags: Curr Med Res Opin Source Type: research